Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that reported normalized Funds From Operations (“FFO”) per diluted common share was $4.47 for the year ended December 31, 2015. Reported normalized FFO for the year ended December 31, 2015 was $1.5 billion. Weighted average diluted shares outstanding for the full year increased to 334.0 million, compared to 296.7 million in 2014.

Reported normalized FFO per diluted common share was $1.03 for the fourth quarter of 2015. Fourth quarter 2015 reported normalized FFO was $346.3 million, compared to $342.2 million for the 2014 period.

These current and prior period reported results include in discontinued operations normalized FFO from the 355 properties that are now owned by Care Capital Properties, Inc. (“CCP”) (NYSE:CCP). The spin-off of CCP as an independent, publicly traded company (the “Spin-Off”) was successfully completed on August 17, 2015. Ventas’s full year 2015 reported results include normalized FFO from those properties for the period January 1 to August 17, 2015.

Normalized FFO for the year ended December 31, 2015 grew 9 percent on a comparable basis (“Comparable”), which adjusts all current and prior periods for the effects of the Spin-Off as if the Spin-Off were completed January 1, 2014. Full-year 2015 Comparable normalized FFO totaled $1.3 billion or $3.95 cents per diluted share. Normalized FFO for the fourth quarter of 2015 grew 7 percent compared to the fourth quarter 2014 on a Comparable basis.

Track Record of Excellence Demonstrated in 2015

“Ventas continued its long track record of consistent outperformance with another exceptional year in 2015,” Ventas Chairman and Chief Executive Officer Debra A. Cafaro said. “Our innovative and value creating spin-off of Care Capital Properties improved the quality of our diversified portfolio and our acquisition of the hospital real estate network of Ardent, a top ten hospital operator, advanced our strategy of building a formidable business in the large, growing and fragmented acute care space. At the same time, the Company delivered superior results to shareholders through 9 percent Comparable FFO per share growth and a 10 percent dividend increase (combined with CCP).

“The Ventas advantage combines our outstanding people, our leading operating partners and our diversified, high quality properties. This unique advantage has enabled us to lead the market and deliver results for shareholders for almost two decades, and gives us confidence that we will sustain our record of excellence into 2016 and beyond,” Cafaro added.

Fourth Quarter and Full Year Net Income and NAREIT FFO

Reported net income attributable to common stockholders for the year ended December 31, 2015 was $417.8 million, or $1.25 per diluted common share. Reported net income attributable to common stockholders for the year ended December 31, 2014 was $475.8 million, or $1.60 per diluted common share.

Reported net income attributable to common stockholders for the quarter ended December 31, 2015 was $124.7 million, or $0.37 per diluted common share. Reported net income attributable to common stockholders for the quarter ended December 31, 2014 was $107.2 million, or $0.36 per diluted common share.

The decrease in full year 2015 reported net income per share from 2014 net income per share is principally due to the inclusion in 2014 of a full year’s results from the properties that were spun off to CCP; higher depreciation expense; and separation and transaction costs in the current year principally related to the Spin-Off and the Ardent transactions. These factors were partially offset by higher net operating income (“NOI”) due to accretive investments and improved property performance in 2015.

Reported FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT FFO”), for the year ended December 31, 2015 was $1.4 billion, or $4.09 per diluted common share. NAREIT FFO for the fourth quarter of 2015 was $356.9 million, or $1.06 per diluted common share.

Portfolio Performance

  • For the year ended December 31, 2015, same-store cash NOI growth for the Company’s total portfolio (1,008) assets was 3.8 percent compared to 2014, in-line with previous company guidance of 3.5 to 4 percent. For the quarter ended December 31, 2015 same-store cash NOI growth for the Company’s total portfolio (1,056) assets was 1.7 percent.
  • At a segment level for full year 2015: triple net same-store cash NOI grew 5.8 percent; the seniors housing operating portfolio (“SHOP”) same-store NOI grew 2.3 percent, consistent with previous guidance; and the medical office building (“MOB”) portfolio grew 2 percent.

2015 and Fourth Quarter Highlights

  • Ventas completed the innovative and strategic spin-off of Care Capital Properties and acquired $1.3 billion of Ardent’s hospital real estate network, further enhancing and diversifying the Company’s high-quality portfolio and creating a platform for growth.
  • The Company made $5.2 billion in acquisitions in 2015. In addition, Ventas committed to funding approximately $350 million in new development and redevelopment projects, primarily in seniors housing and medical office buildings.
  • In the fourth quarter of 2015, the Company acquired $93 million in high quality MOBs that were previously managed by the Company and in which the Company had a minority interest.
  • In the fourth quarter, the Company committed to funding approximately $240 million in new high-quality development and redevelopment projects, including:
    • A $166 million ($150 million at the Company’s share), 233,000 square foot multi-tenant “trophy” medical office building development in a 90 / 10 joint venture with Ventas’s existing development partner, Pacific Medical Buildings. The development is located in downtown San Francisco and is connected to Sutter Health’s (AA-; Standard & Poor’s) new flagship hospital, which is currently under construction. The project is expected to be 75 percent leased upon opening.
    • The redevelopment of four Atria communities totaling $86 million. The communities are located in top coastal markets including New York, San Francisco and Philadelphia.
  • The Company sold 65 properties and received final repayment on loans receivable for aggregate proceeds of approximately $708 million in 2015. Of these dispositions, 8 properties were sold during the fourth quarter, generating proceeds of $105 million.
  • Ventas paid its shareholders dividends of $3.04 per share in 2015. Ventas also distributed, on a tax free basis, shares of CCP valued at $8.51 per Ventas share to effectuate the Spin-Off.
  • To fund new investments, Ventas issued and sold a total of 1.4 million shares of common stock in the fourth quarter for aggregate proceeds of approximately $75 million at an average gross price of $54.87 (before sales commissions) under its “at the market” equity offering program. For the full-year of 2015, Ventas issued and sold 7.2 million shares of common stock for aggregate proceeds of approximately $500 million under its “at the market” equity offering program. 5.8 million of these shares were issued prior to the Spin-Off at an average price of $72.94 (before sales commissions) and 1.4 million shares were issued following the Spin-Off at an average price of $54.87 (before sales commissions).
  • The Company’s credit profile was strong at year-end, including fixed charge coverage of 4.5x, net debt to adjusted pro forma EBITDA of 6.1x, and a weighted average maturity approximating 7 years. At year-end, Ventas’s debt to total capitalization was 37 percent.

Recent Developments

  • To fund new investments, Ventas issued and sold a total of 1.6 million shares of common stock since January 1, 2016 for aggregate proceeds of approximately $92 million at an average gross price of $55.88 (before sales commissions) under its “at the market” equity offering program. The Company’s fully diluted full year 2016 share count is assumed to be 340.4 million.
  • Since January 1, 2016 Ventas has sold 6 properties for aggregate proceeds of approximately $61 million.
  • The Company currently has a strong liquidity position, with approximately $2.0 billion available under its revolving credit facility, as well as $236 million of cash on hand.

First Quarter Dividend

The Company said today that its Board of Directors declared a dividend for the first quarter of $0.73 per share. The dividend is payable in cash on March 31, 2016 to stockholders of record on March 7, 2016.

2016 Guidance Range for Reported Normalized FFO of $4.07 to $4.15 Per Diluted Share

Ventas currently expects its 2016 reported normalized FFO per diluted share to range between $4.07 and $4.15, representing 3 to 5 percent growth over 2015 on a Comparable basis. Ventas currently expects its 2016 NAREIT reported FFO per diluted share to be between $4.13 and $4.21.

Total Company same-store cash NOI is forecast to grow 1.5 to 3 percent in 2016. Triple-net same-store cash NOI is forecast to grow 2 to 3 percent, SHOP same-store cash NOI is forecast to grow 1 to 3 percent and MOB same-store cash NOI is estimated to grow 1 to 2 percent in 2016.

The Company’s guidance assumes continued sale of assets, estimating $500 million in proceeds in 2016. The net proceeds are assumed to be reinvested in approximately $350 million in acquisitions and to fund development and redevelopment projects.

Consistent with its practice, the Company’s guidance does not include any further material investments, dispositions or capital activity. A modest reduction in leverage in 2016 to below 6x net debt to adjusted pro forma EBITDA is also assumed in its guidance. A reconciliation of the Company’s guidance to the Company’s projected GAAP earnings is included in this press release.

The Company’s guidance is based on a number of other assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company’s expectations may change. There can be no assurance that the Company will achieve these results.

FOURTH QUARTER CONFERENCE CALL

Ventas will hold a conference call to discuss this earnings release today at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (877) 703-6105 (or (857) 244-7304 for international callers). The participant passcode is “Ventas.” The conference call is being webcast live by NASDAQ OMX and can be accessed at the Company’s website at www.ventasreit.com. A replay of the webcast will be available following the call online, or by calling (888) 286-8010 (or (617) 801-6888 for international callers), passcode 97749067, beginning at approximately 2:00 p.m. Eastern Time and will remain for 35 days.

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,300 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, skilled nursing facilities, specialty hospitals and general acute care hospitals. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

Supplemental information regarding the Company can be found on the Company’s website under the “Investor Relations” section or at www.ventasreit.com/investor-relations/financial-information/supplemental-information. A comprehensive listing of the Company’s properties is available at www.ventasreit.com/our-portfolio/properties-by-location.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s or its tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, merger or acquisition integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust (“REIT”), plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from the Company’s expectations. The Company does not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

The Company’s actual future results and trends may differ materially from expectations depending on a variety of factors discussed in the Company’s filings with the Securities and Exchange Commission. These factors include without limitation: (a) the ability and willingness of the Company’s tenants, operators, borrowers, managers and other third parties to satisfy their obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the Company’s tenants, operators, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities and other indebtedness; (c) the Company’s success in implementing its business strategy and the Company’s ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments; (d) macroeconomic conditions such as a disruption of or lack of access to the capital markets, changes in the debt rating on U.S. government securities, default or delay in payment by the United States of its obligations, and changes in the federal or state budgets resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; (e) the nature and extent of future competition, including new construction in the markets in which the Company’s seniors housing communities and medical office buildings (“MOBs”) are located; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company’s borrowing costs as a result of changes in interest rates and other factors; (h) the ability of the Company’s tenants, operators and managers, as applicable, to comply with laws, rules and regulations in the operation of the Company’s properties, to deliver high-quality services, to attract and retain qualified personnel and to attract residents and patients; (i) changes in general economic conditions or economic conditions in the markets in which the Company may, from time to time, compete, and the effect of those changes on the Company’s revenues, earnings and funding sources; (j) the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; (k) the Company’s ability and willingness to maintain its qualification as a REIT in light of economic, market, legal, tax and other considerations; (l) final determination of the Company’s taxable net income for the year ended December 31, 2015 and for the year ending December 31, 2016; (m) the ability and willingness of the Company’s tenants to renew their leases with the Company upon expiration of the leases, the Company’s ability to reposition its properties on the same or better terms in the event of nonrenewal or in the event the Company exercises its right to replace an existing tenant, and obligations, including indemnification obligations, the Company may incur in connection with the replacement of an existing tenant; (n) risks associated with the Company’s senior living operating portfolio, such as factors that can cause volatility in the Company’s operating income and earnings generated by those properties, including without limitation national and regional economic conditions, costs of food, materials, energy, labor and services, employee benefit costs, insurance costs and professional and general liability claims, and the timely delivery of accurate property-level financial results for those properties; (o) changes in exchange rates for any foreign currency in which the Company may, from time to time, conduct business; (p) year-over-year changes in the Consumer Price Index or the UK Retail Price Index and the effect of those changes on the rent escalators contained in the Company’s leases and the Company’s earnings; (q) the Company’s ability and the ability of its tenants, operators, borrowers and managers to obtain and maintain adequate property, liability and other insurance from reputable, financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the Company’s liquidity, financial condition and results of operations or that of the Company’s tenants, operators, borrowers and managers, and the ability of the Company and the Company’s tenants, operators, borrowers and managers to accurately estimate the magnitude of those claims; (s) risks associated with the Company’s MOB portfolio and operations, including the Company’s ability to successfully design, develop and manage MOBs and to retain key personnel; (t) the ability of the hospitals on or near whose campuses the Company’s MOBs are located and their affiliated health systems to remain competitive and financially viable and to attract physicians and physician groups; (u) risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition; (v) the impact of market or issuer events on the liquidity or value of the Company’s investments in marketable securities; (w) consolidation activity in the seniors housing and healthcare industries resulting in a change of control of, or a competitor’s investment in, one or more of the Company’s tenants, operators, borrowers or managers or significant changes in the senior management of the Company’s tenants, operators, borrowers or managers; (x) the impact of litigation or any financial, accounting, legal or regulatory issues that may affect the Company or its tenants, operators, borrowers or managers; and (y) changes in accounting principles, or their application or interpretation, and the Company’s ability to make estimates and the assumptions underlying the estimates, which could have an effect on the Company’s earnings.

 
CONSOLIDATED BALANCE SHEETS
As of December 31, 2015, September 30, 2015, June 30, 2015, March 31, 2015 and December 31, 2014
(In thousands, except per share amounts)
         
December 31, September 30, June 30, March 31, December 31,
2015 2015 2015 2015 2014
 
Assets
Real estate investments:
Land and improvements $ 2,056,428 $ 2,068,467 $ 2,016,281 $ 1,974,013 $ 1,711,654
Buildings and improvements 20,309,599 20,220,624 19,247,902 19,049,345 17,420,392
Construction in progress 92,005 124,381 129,186 118,483 109,689
Acquired lease intangibles 1,344,422   1,347,493   1,214,702   1,197,567   955,035  
23,802,454 23,760,965 22,608,071 22,339,408 20,196,770
Accumulated depreciation and amortization (4,177,234 ) (3,972,544 ) (3,780,388 ) (3,569,773 ) (3,423,780 )
Net real estate property 19,625,220 19,788,421 18,827,683 18,769,635 16,772,990
Secured loans receivable and investments, net 857,112 766,707 762,312 746,793 802,881
Investments in unconsolidated real estate entities 95,707   96,208   85,461   95,147   91,872  
Net real estate investments 20,578,039 20,651,336 19,675,456 19,611,575 17,667,743
Cash and cash equivalents 53,023 65,231 60,532 120,225 55,348
Escrow deposits and restricted cash 77,896 74,491 193,960 223,772 71,771
Goodwill 1,047,497 1,052,321 1,058,607 947,386 363,971
Assets held for sale 93,060 152,014 2,822,553 3,012,994 2,555,322
Other assets 412,403   418,584   395,770   452,533   451,758  
Total assets $ 22,261,918   $ 22,413,977   $ 24,206,878   $ 24,368,485   $ 21,165,913  
 
Liabilities and equity
Liabilities:
Senior notes payable and other debt $ 11,206,996 $ 11,284,957 $ 11,456,038 $ 11,549,062 $ 10,844,351
Accrued interest 80,864 67,440 77,713 77,444 62,182
Accounts payable and other liabilities 779,380 791,556 784,547 777,595 750,657
Liabilities related to assets held for sale 34,340 48,860 225,269 222,389 237,973
Deferred income taxes 338,382   352,658   370,161   371,785   344,337  
Total liabilities 12,439,962 12,545,471 12,913,728 12,998,275 12,239,500
 
Redeemable OP unitholder and noncontrolling interests 196,529 198,832 199,404 257,246 172,016
 
Commitments and contingencies
 
Equity:
Ventas stockholders' equity:
Preferred stock, $1.00 par value; 10,000 shares authorized, unissued
Common stock, $0.25 par value; 334,386; 333,027; 331,965; 330,913 and 298,478 shares issued at December 31, 2015, September 30, 2015, June 30, 2015, March 31, 2015 and December 31, 2014, respectively 83,579 83,238 82,982 82,718 74,656
Capital in excess of par value 11,602,838 11,523,312 12,708,898 12,616,056 10,119,306
Accumulated other comprehensive (loss) income (7,565 ) (592 ) 10,180 4,357 13,121
Retained earnings (deficit) (2,111,958 ) (1,992,848 ) (1,772,529 ) (1,660,856 ) (1,526,388 )
Treasury stock, 44; 61; 28; 32 and 7 shares at December 31, 2015, September 30, 2015, June 30, 2015, March 31, 2015 and December 31, 2014, respectively (2,567 ) (3,675 ) (2,048 ) (2,385 ) (511 )
Total Ventas stockholders' equity 9,564,327 9,609,435 11,027,483 11,039,890 8,680,184
Noncontrolling interest 61,100   60,239   66,263   73,074   74,213  
Total equity 9,625,427   9,669,674   11,093,746   11,112,964   8,754,397  
Total liabilities and equity $ 22,261,918   $ 22,413,977   $ 24,206,878   $ 24,368,485   $ 21,165,913  

 
CONSOLIDATED STATEMENTS OF INCOME
For the three months and years ended December 31, 2015 and 2014
(In thousands, except per share amounts)
       
For the Three Months Ended For the Year Ended
December 31, December 31,
2015 2014 2015 2014
Revenues:
Rental income:
Triple-net leased $ 208,210 $ 174,500 $ 779,801 $ 674,547
Medical office buildings 145,958   116,968   566,245   463,910  
354,168 291,468 1,346,046 1,138,457
Resident fees and services 454,871 411,170 1,811,255 1,552,951
Medical office building and other services revenue 11,541 11,124 41,492 29,364
Income from loans and investments 20,361 14,876 86,553 51,778
Interest and other income 333   3,452   1,052   4,263  
Total revenues 841,274 732,090 3,286,398 2,776,813
Expenses:
Interest 103,692 77,948 367,114 292,065
Depreciation and amortization 236,795 218,049 894,057 725,216
Property-level operating expenses:
Senior living 307,261 273,563 1,209,415 1,036,556
Medical office buildings 45,073   38,811   174,225   158,832  
352,334 312,374 1,383,640 1,195,388
Medical office building services costs 7,467 7,527 26,565 17,092
General, administrative and professional fees 27,636 28,106 128,035 121,738
(Gain) loss on extinguishment of debt, net (486 ) 485 14,411 5,564
Merger-related expenses and deal costs (2,079 ) 7,360 102,944 43,304
Other 4,009   7,673   17,957   25,743  
Total expenses 729,368   659,522   2,934,723   2,426,110  
Income before loss from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest 111,906 72,568 351,675 350,703
Loss from unconsolidated entities (223 ) (688 ) (1,420 ) (139 )
Income tax benefit 11,548   13,552   39,284   8,732  
Income from continuing operations 123,231 85,432 389,539 359,296
Discontinued operations (2,331 ) 20,709 11,103 99,735
Gain on real estate dispositions 4,160   1,456   18,580   17,970  
Net income 125,060 107,597 419,222 477,001
Net income attributable to noncontrolling interest 332   407   1,379   1,234  
Net income attributable to common stockholders $ 124,728   $ 107,190   $ 417,843   $ 475,767  
Earnings per common share:
Basic:
Income from continuing operations attributable to common stockholders, including real estate dispositions $ 0.38 $ 0.29 $ 1.23 $ 1.28
Discontinued operations (0.01 ) 0.07   0.03   0.34  
Net income attributable to common stockholders $ 0.37   $ 0.36   $ 1.26   $ 1.62  
Diluted:
Income from continuing operations attributable to common stockholders, including real estate dispositions $ 0.38 $ 0.29 $ 1.22 $ 1.26
Discontinued operations (0.01 ) 0.07   0.03   0.34  
Net income attributable to common stockholders $ 0.37   $ 0.36   $ 1.25   $ 1.60  
 
Weighted average shares used in computing earnings per common share:
Basic 332,914 294,810 330,311 294,175
Diluted 336,406 297,480 334,007 296,677
 
Dividends declared per common share $ 0.73 $ 0.79 $ 3.04 $ 2.965

 
QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
         
2015 Quarters 2014 Fourth
Fourth Third Second First Quarter
 
Revenues:
Rental income:
Triple-net leased $ 208,210 $ 201,028 $ 182,006 $ 188,557 $ 174,500
Medical office buildings 145,958   142,755   140,472   137,060   116,968  
354,168 343,783 322,478 325,617 291,468
Resident fees and services 454,871 454,825 454,645 446,914 411,170
Medical office building and other services revenue 11,541 10,000 9,408 10,543 11,124
Income from loans and investments 20,361 18,924 25,215 22,053 14,876
Interest and other income 333   74   174   471   3,452  
Total revenues 841,274 827,606 811,920 805,598 732,090
 
Expenses:
Interest 103,692 97,135 83,959 82,328 77,948
Depreciation and amortization 236,795 226,332 214,711 216,219 218,049
Property-level operating expenses:
Senior living 307,261 304,540 299,252 298,362 273,563
Medical office buildings 45,073   43,305   43,410   42,437   38,811  
352,334 347,845 342,662 340,799 312,374
Medical office building services costs 7,467 6,416 5,764 6,918 7,527
General, administrative and professional fees 27,636 32,114 33,959 34,326 28,106
(Gain) loss on extinguishment of debt, net (486 ) 15,331 (455 ) 21 485
Merger-related expenses and deal costs (2,079 ) 62,145 12,265 30,613 7,360
Other 4,009   4,795   4,279   4,874   7,673  
Total expenses 729,368   792,113   697,144   716,098   659,522  
 
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest 111,906 35,493 114,776 89,500 72,568
(Loss) income from unconsolidated entities (223 ) (955 ) 9 (251 ) (688 )
Income tax benefit 11,548   10,697   9,789   7,250   13,552  
Income from continuing operations 123,231 45,235 124,574 96,499 85,432
Discontinued operations (2,331 ) (22,383 ) 18,243 17,574 20,709
Gain on real estate dispositions 4,160   265   7,469   6,686   1,456  
Net income 125,060 23,117 150,286 120,759 107,597
Net income attributable to noncontrolling interest 332   265   465   317   407  
Net income attributable to common stockholders $ 124,728   $ 22,852   $ 149,821   $ 120,442   $ 107,190  
 
Earnings per common share:
Basic:
Income from continuing operations attributable to common stockholders, including real estate dispositions $ 0.38 $ 0.14 $ 0.39 $ 0.32 $ 0.29
Discontinued operations (0.01 ) (0.07 ) 0.06   0.05   0.07  
Net income attributable to common stockholders $ 0.37   $ 0.07   $ 0.45   $ 0.37   $ 0.36  
Diluted:
Income from continuing operations attributable to common stockholders, including real estate dispositions $ 0.38 $ 0.14 $ 0.40 $ 0.32 $ 0.29
Discontinued operations (0.01 ) (0.07 ) 0.05   0.05   0.07  
Net income attributable to common stockholders $ 0.37   $ 0.07   $ 0.45   $ 0.37   $ 0.36  
 
Weighted average shares used in computing earnings per common share:
Basic 332,914 332,491 330,715 325,454 294,810
Diluted 336,406 336,338 334,026 329,203 297,480

 
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the years ended December 31, 2015 and 2014
(In thousands)
  2015   2014
Cash flows from operating activities:
Net income $ 419,222 $ 477,001
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 973,663 828,467
Amortization of deferred revenue and lease intangibles, net (24,129 ) (18,871 )
Other non-cash amortization 5,448 (312 )
Stock-based compensation 19,537 20,994
Straight-lining of rental income, net (33,792 ) (38,687 )
Loss on extinguishment of debt, net 14,411 5,564
Gain on real estate dispositions (including amounts in discontinued operations) (18,811 ) (19,183 )
Gain on real estate loan investments (1,455 )
Gain on sale of marketable securities (5,800 )
Income tax benefit (42,384 ) (9,431 )
Loss from unconsolidated entities 1,244 139
Loss on re-measurement of equity interest upon acquisition, net 176
Distributions from unconsolidated entities 23,462 6,508
Other 6,517 9,416
Changes in operating assets and liabilities:
Decrease in other assets 42,316 5,317
Increase in accrued interest 19,995 7,958
Decrease in accounts payable and other liabilities (9,308 ) (18,580 )
Net cash provided by operating activities 1,391,767 1,254,845
Cash flows from investing activities:
Net investment in real estate property (2,650,788 ) (1,468,286 )
Investment in loans receivable and other (171,144 ) (498,992 )
Proceeds from real estate disposals 492,408 118,246
Proceeds from loans receivable 109,176 73,557
Purchase of marketable securities (96,689 )
Proceeds from sale or maturity of marketable securities 76,800 21,689
Funds held in escrow for future development expenditures 4,003 4,590
Development project expenditures (119,674 ) (106,988 )
Capital expenditures (107,487 ) (87,454 )
Investment in unconsolidated operating entity (26,282 )
Other (30,704 ) (14,713 )
Net cash used in investing activities (2,423,692 ) (2,055,040 )
Cash flows from financing activities:
Net change in borrowings under credit facility (723,457 ) 540,203
Net cash impact of CCP Spin-off (128,749 )
Proceeds from debt 2,512,747 2,007,707
Proceeds from debt related to CCP Spin-off 1,400,000
Repayment of debt (1,435,596 ) (1,151,395 )
Purchase of noncontrolling interest (3,819 )
Payment of deferred financing costs (24,665 ) (14,220 )
Issuance of common stock, net 491,023 242,107
Cash distribution to common stockholders (1,003,413 ) (875,614 )
Cash distribution to redeemable OP unitholders (15,095 ) (5,762 )
Purchases of redeemable OP units (33,188 ) (503 )
Contributions from noncontrolling interest 491
Distributions to noncontrolling interest (12,649 ) (9,559 )
Other 6,983   24,602  
Net cash provided by financing activities 1,030,122   758,057  
Net decrease in cash and cash equivalents (1,803 ) (42,138 )
Effect of foreign currency translation on cash and cash equivalents (522 ) 2,670
Cash and cash equivalents at beginning of period 55,348   94,816  
Cash and cash equivalents at end of period $ 53,023   $ 55,348  
 
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ 2,565,960 $ 370,741
Utilization of funds held for an Internal Revenue Code Section 1031 exchange (8,911 )
Other assets acquired 20,090 15,280
Debt assumed 177,857 241,076
Other liabilities 54,459 24,039
Deferred income tax liability 52,153 110,728
Noncontrolling interests 88,085
Equity issued 2,204,585 10,178
Non-cash impact of CCP Spin-Off 1,256,404

 
QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
         
2015 Quarters 2014 Fourth
Fourth Third Second First Quarter
Cash flows from operating activities:
Net income $ 125,060 $ 23,117 $ 150,286 $ 120,759 $ 107,597
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 236,793 240,210 249,207 247,453 241,291
Amortization of deferred revenue and lease intangibles, net (4,817 ) (5,682 ) (7,027 ) (6,603 ) (4,096 )
Other non-cash amortization 2,397 2,142 1,428 (519 ) 304
Stock-based compensation 3,476 4,869 4,885 6,307 4,202
Straight-lining of rental income, net (8,674 ) (8,357 ) (8,082 ) (8,679 ) (9,043 )
(Gain) loss on extinguishment of debt, net (486 ) 15,331 (455 ) 21 485
Gain on real estate dispositions (including amounts in discontinued operations) (4,162 ) (217 ) (7,746 ) (6,686 ) (1,457 )
Gain on real estate loan investments (1,206 )
Gain on sale of marketable securities (5,800 )
Income tax benefit (11,667 ) (12,477 ) (10,390 ) (7,850 ) (13,851 )
Loss (income) from unconsolidated entities 47 955 (9 ) 251 688
Loss on re-measurement of equity interest upon acquisition, net 176
Distributions from unconsolidated entities 2,912 5,577 14,324 649 1,121
Other 3,241 170 847 2,259 1,067
Changes in operating assets and liabilities:
Decrease (increase) in other assets 31,152 20,875 (14,326 ) 4,615 8,623
Increase (decrease) in accrued interest 13,657 (9,770 ) 316 15,792 (6,877 )
(Decrease) increase in accounts payable and other liabilities (19,383 ) 27,578   6,097   (23,600 ) 6,025  
Net cash provided by operating activities 369,722 304,321 373,555 344,169 334,873
Cash flows from investing activities:
Net investment in real estate property (93,800 ) (1,303,078 ) (181,371 ) (1,072,539 ) (284,250 )
Investment in loans receivable and other (96,758 ) (18,727 ) (16,086 ) (39,573 ) (432,556 )
Proceeds from real estate disposals 82,775 136,442 106,850 166,341 5,500
Proceeds from loans receivable 2,267 13,634 1,219 92,056 17,984
Purchase of marketable securities (50,000 )
Proceeds from sale or maturity of marketable securities 19,575 57,225
Funds held in escrow for future development expenditures 4,003 1,988
Development project expenditures (29,216 ) (27,828 ) (29,163 ) (33,467 ) (35,613 )
Capital expenditures (31,675 ) (32,383 ) (22,258 ) (21,171 ) (31,219 )
Investment in unconsolidated operating entity (26,282 )
Other (2,720 ) (19,171 ) (4,633 ) (4,180 ) (10,704 )
Net cash used in investing activities (169,127 ) (1,257,818 ) (88,217 ) (908,530 ) (818,870 )
Cash flows from financing activities:
Net change in borrowings under credit facility 66,949 (469,072 ) 131,563 (452,897 ) 693,887
Net cash impact of CCP Spin-off (128,749 )
Proceeds from debt 1,686 1,403,090 15,138 1,092,833
Proceeds from debt related to CCP Spin-off 1,400,000
Repayment of debt (106,526 ) (1,050,628 ) (253,795 ) (24,647 ) (246,278 )
Purchase of noncontrolling interest (3 ) (1,156 ) (2,660 )
Payment of deferred financing costs (772 ) (9,285 ) (173 ) (14,435 ) 726
Issuance of common stock, net 73,205 65,651 66,840 285,327 242,107
Cash distribution to common stockholders (243,838 ) (243,171 ) (261,494 ) (254,910 ) (235,200 )
Cash distribution to redeemable OP unitholders (2,319 ) (8,079 ) (2,332 ) (2,365 ) (1,548 )
Purchases of redeemable OP units (32,619 ) (569 ) (503 )
Contributions from noncontrolling interest 491
Distributions to noncontrolling interest (1,399 ) (1,783 ) (7,645 ) (1,822 ) (2,799 )
Other 494   561   238   5,690   25,153  
Net cash (used in) provided by financing activities (212,520 ) 958,532   (345,435 ) 629,545   476,036  
Net (decrease) increase in cash and cash equivalents (11,925 ) 5,035 (60,097 ) 64,535 (7,961 )
Effect of foreign currency translation on cash and cash equivalents (283 ) (336 ) 404 (307 ) (1,286 )
Cash and cash equivalents at beginning of period 65,231   60,532   120,225   55,348   64,595  
Cash and cash equivalents at end of period $ 53,023   $ 65,231   $ 60,532   $ 119,576   $ 55,348  

 
QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(In thousands)
         
2015 Quarters 2014 Fourth
Fourth Third Second First Quarter
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ (1,190 ) $ 3,649 $ 20,672 $ 2,542,829 $ 16,746
Utilization of funds held for an Internal Revenue Code Section 1031 exchange (8,911 )
Other assets acquired (131 ) 3,716 (206 ) 16,711 11,597
Debt assumed 177,857 12,926
Other liabilities (3,478 ) 8,149 4,052 45,736 4,598
Deferred income tax liability 1,317 (784 ) 7,503 44,117 641
Noncontrolling interests 840 87,245
Equity issued 2,204,585 10,178
Non-cash impact of CCP Spin-Off 1,256,404

               
NON-GAAP FINANCIAL MEASURES RECONCILIATION

Funds From Operations (FFO) and Funds Available for Distribution (FAD) Including Comparable Earnings1

(Dollars in thousands, except per share amounts)
 
YOY
2014   2015   Growth
Q4   FY   Q1   Q2   Q3   Q4   YTD   '14-'15
Net income attributable to common stockholders 2 $ 107,190 $ 475,767 $ 120,442 $ 149,821 $ 22,852 $ 124,728 $ 417,843
Net income attributable to common stockholders per share 2$0.36$1.60$0.37$0.45$0.07$0.37$1.25
 
Adjustments:
Depreciation and amortization on real estate assets 216,239 718,649 214,429 212,908 224,688 235,101 887,126
Depreciation on real estate assets related to noncontrolling interest (2,506 ) (10,314 ) (2,052 ) (1,964 ) (1,964 ) (1,926 ) (7,906 )
Depreciation on real estate assets related to unconsolidated entities 1,332 5,792 1,462 1,464 1,445 2,982 7,353
Loss on re-measurement of equity interest upon acquisition, net 176 176
Gain on real estate dispositions (1,456 ) (17,970 ) (6,686 ) (7,469 ) (265 ) (4,160 ) (18,580 )
Discontinued operations:
(Gain) loss on real estate dispositions (52 ) (1,494 ) (277 ) 48 17 (212 )
Depreciation and amortization on real estate assets 23,241     103,250     31,234     34,496     13,878         79,608      
Subtotal: FFO add-backs 236,798 797,913 238,387 239,158 237,830 232,190 947,565
Subtotal: FFO add-backs per share   $0.80     $2.69     $0.72     $0.72     $0.71     $0.69     $2.84      
FFO (NAREIT) attributable to common stockholders $ 343,988 $ 1,273,680 $ 358,829 $ 388,979 $ 260,682 $ 356,918 $ 1,365,408 7 %
FFO (NAREIT) attributable to common stockholders per share   $1.16     $4.29     $1.09     $1.16     $0.78     $1.06     $4.09     (5%)
 
Adjustments:
Change in fair value of financial instruments 485 5,121 (46 ) 70 (18 ) 454 460
Non-cash income tax benefit (13,851 ) (9,431 ) (7,850 ) (10,389 ) (12,477 ) (11,668 ) (42,384 )
Loss (gain) on extinguishment of debt, net 485 5,013 21 (39 ) 16,301 (486 ) 15,797
Merger-related expenses, deal costs and re-audit costs 10,625 54,389 36,002 15,135 100,548 659 152,344
Amortization of other intangibles 480     1,246     591     591     438     438     2,058      
Subtotal: normalized FFO add-backs (1,776 ) 56,338 28,718 5,368 104,792 (10,603 ) 128,275
Subtotal: normalized FFO add-backs per share   $(0.01)   $0.19     $0.09     $0.02     $0.31     $(0.03)   $0.38      
Normalized FFO attributable to common stockholders $ 342,212 $ 1,330,018 $ 387,547 $ 394,347 $ 365,474 $ 346,315 $ 1,493,683 12 %
Normalized FFO attributable to common stockholders per share$1.15$4.48$1.18$1.18$1.09$1.03$4.47(0%)
Adjusted: Normalized FFO from CCP spin-off (57,051 ) (250,100 ) (68,701 ) (69,306 ) (35,393 ) (173,400 )
Adjusted Normalized FFO from CCP spin-off per share$(0.19)$(0.84)$(0.21)$(0.21)$(0.11)$$(0.52)
Comparable Normalized FFO attributable to common stockholders $ 285,161 $ 1,079,918 $ 318,846 $ 325,041 $ 330,081 $ 346,315 $ 1,320,283 22 %
Comparable Normalized FFO attributable to common stockholders per share   $0.96     $3.64     $0.97     $0.97     $0.98     $1.03     $3.95     9%
 
Non-cash items included in normalized FFO:
Amortization of deferred revenue and lease intangibles, net (4,096 ) (18,871 ) (6,603 ) (7,027 ) (5,682 ) (4,817 ) (24,129 )
Other non-cash amortization, including fair market value of debt 304 (312 ) (519 ) 1,428 2,142 2,397 5,448
Stock-based compensation 4,202 20,994 6,307 4,885 4,869 3,476 19,537
Straight-lining of rental income, net (9,043 )   (38,687 )   (8,679 )   (8,082 )   (8,357 )   (8,674 )   (33,792 )    
Subtotal: non-cash items included in normalized FFO (8,633 ) (36,876 ) (9,494 ) (8,796 ) (7,028 ) (7,618 ) (32,936 )
Capital expenditures   (32,527 )   (92,928 )   (22,148 )   (23,520 )   (33,536 )   (33,496 )   (112,700 )    
Normalized FAD attributable to common stockholders $ 301,052 $ 1,200,214 $ 355,905 $ 362,031 $ 324,910 $ 305,201 $ 1,348,047 12 %
Normalized FAD attributable to common stockholders per share$1.01$4.05$1.08$1.08$0.97$0.91$4.04(0%)
Adjusted: Normalized FAD from CCP spin-off (51,535 ) (230,477 ) (61,014 ) (64,080 ) (29,987 ) (155,081 )
Adjusted: Normalized FAD from CCP spin-off per share$(0.17)$(0.78)$(0.19)$(0.19)$(0.09)$$(0.46)
Comparable Normalized FAD attributable to common stockholders 3 $ 249,517 $ 969,737 $ 294,891 $ 297,951 $ 294,923 $ 305,201 $ 1,192,966 23 %
Comparable Normalized FAD attributable to common stockholders per share 3   $0.84     $3.27     $0.90     $0.89     $0.88     $0.91     $3.57     9%
Merger-related expenses, deal costs and re-audit costs   (10,625 )   (54,389 )   (36,002 )   (15,135 )   (100,548 )   (659 )   (152,344 )    
FAD attributable to common stockholders $ 290,427 $ 1,145,825 $ 319,903 $ 346,896 $ 224,362 $ 304,542 $ 1,195,703 4 %
FAD attributable to common stockholders per share$0.98$3.86$0.97$1.04$0.67$0.91$3.58(7%)
Adjusted: FAD from CCP spin-off (50,952 ) (228,730 ) (56,454 ) (61,760 ) 7,204 2,333 (108,677 )
Adjusted FAD from CCP spin-off per share$(0.17)$(0.77)$(0.17)$(0.18)$0.02$0.01$(0.33)
Comparable FAD attributable to common stockholders $ 239,475 $ 917,095 $ 263,449 $ 285,136 $ 231,566 $ 306,875 $ 1,087,026 19 %
Comparable FAD attributable to common stockholders per share   $0.81     $3.09     $0.80     $0.85     $0.69     $0.91     $3.25     5%
Weighted average diluted shares 297,480 296,677 329,203 334,026 336,338 336,406 334,007
 
1 Totals and per share amounts may not add due to rounding. Per share quarterly amounts may not add to annual per share amounts due to material changes in the Company’s weighted average diluted share count, if any.
 
2 CCP impacts calculated based on net income related to discontinued operations, less the de minimis share of discontinued operations net income not related to CCP assets, assuming (a) G&A of $2.5 million in Q4’14 ($0.01 per share), $10.0 million for the full-year of 2014 ($0.03 per share), $2.5 million in Q1’15 and Q2’15 ($0.01 per share per quarter), and $1.3 million in Q3’15 ($0.00 per share) and (b) interest expense of $6.5 million in Q4’14 ($0.02 per share), $26.1 million for the full-year 2014 ($0.09 per share), $6.9 million in Q1’15 and Q2’15 ($0.02 per share per quarter), and $4.3 million in Q3’15 ($0.01 per share); these adjustments differ from the respective amounts found in discontinued operations.
 
3 Q1’14, Q2’14 and Q3'14 Comparable Normalized FAD represents $235,126 / $0.79 per share, $238,724 / $0.80 per share and $223,530 / $0.75 per share, respectively.
 

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers FFO, normalized FFO, FAD and normalized FAD to be appropriate measures of operating performance of an equity REIT. In particular, the Company believes that normalized FFO is useful because it allows investors, analysts and Company management to compare the Company’s operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items and other events such as transactions and litigation. In some cases, the Company provides information about identified non-cash components of FFO and normalized FFO because it allows investors, analysts and Company management to assess the impact of those items on the Company’s financial results.

The Company uses the NAREIT definition of FFO. NAREIT defines FFO as net income attributable to common stockholders (computed in accordance with GAAP) excluding gains (or losses) from sales of real estate property, including gain (or loss) on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. The Company defines normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) merger-related costs and expenses, including amortization of intangibles, transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to acquisition lawsuits; (b) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company’s debt; (c) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company’s income statement; (d) except as specifically stated in the case of guidance, the impact of future acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions; (e) the financial impact of contingent consideration, severance-related costs, charitable donations made to the Ventas Charitable Foundation, gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments; and (f) expenses related to the re-audit and re-review in 2014 of the Company’s historical financial statements and related matters. Normalized FAD represents normalized FFO excluding non-cash components, straight-line rental adjustments and deducting capital expenditures, including tenant allowances and leasing commissions. FAD represents normalized FAD after subtracting merger-related expenses, deal costs and re-audit costs.

FFO, normalized FFO, FAD and normalized FAD presented herein may not be identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. FFO, normalized FFO, FAD and normalized FAD should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company’s financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company’s needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO, normalized FFO, FAD and normalized FAD should be examined in conjunction with net income as presented elsewhere herein.

       
NON-GAAP FINANCIAL MEASURES RECONCILIATION

EPS, FFO and FAD Guidance Attributable to Common Shareholders 1

(Dollars in millions, except per share amounts)
 
 
Tentative / Preliminary and Subject to Change
FY2016 - Guidance 2016 - Per Share
Low   High Low   High
                 
Net Income Attributable to Common Stockholders   $645   $664   $1.89   $1.95
 
Depreciation and Amortization Adjustments 867 907 2.55 2.67
Other Adjustments 2 (107 ) (139 ) (0.31 ) (0.41 )
                 
FFO (NAREIT) Attributable to Common Stockholders   $1,405   $1,432   $4.13   $4.21
 
Merger-Related Expenses, Deal Costs and Re-Audit Costs 5 10 0.01 0.03
Other Adjustments 2 (26 ) (30 ) (0.07 ) (0.09 )
                 
Normalized FFO Attributable to Common Stockholders $1,384 $1,412 $4.07 $4.15
% Year-Over-Year Comparable Growth           3 %   5 %
 
Capital expenditures (120 ) (130 ) (0.35 ) (0.38 )
Other Adjustments 2 (15 ) (17 ) (0.04 ) (0.05 )
                 
Normalized FAD Attributable to Common Stockholders $1,249 $1,265 $3.67 $3.72
% Year-Over-Year Comparable Growth           3 %   4 %
 
Merger-Related Expense, Deal Costs and Re-Audit Costs (5 ) (10 ) (0.01 ) (0.03 )
Other Adjustments 2 1 1 0.00 0.00
                 
FAD Attributable to Common Stockholders $1,245 $1,256 $3.66 $3.69
% Year-Over-Year Comparable Growth           13 %   14 %
 
Weighted Average Diluted Shares 340,357 340,357

1

  Totals and per share amounts may not add due to rounding. Per share quarterly amounts may not add to annual per share amounts due to changes in the Company's weighted average diluted share count, if any.

2

See Funds From Operations (FFO) and Funds Available for Distribution (FAD) Including Comparable Earnings table for detailed breakout of “other adjustments” for each respective category.

 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Net Debt to Adjusted Pro Forma EBITDA

 
The following information considers the pro forma effect on net income of the Company’s investments and other capital transactions that were completed during the three months ended December 31, 2015, as if the transactions had been consummated as of the beginning of the period. The following table illustrates net debt to pro forma earnings before interest, taxes, depreciation and amortization (including non-cash stock-based compensation expense), excluding gains or losses on extinguishment of debt, income or loss from noncontrolling interest and unconsolidated entities (excluding cash distributions), merger-related expenses and deal costs, expenses related to the re-audit and re-review in 2014 of the Company’s historical financial statements, net gains on real estate activity, gains or losses on re-measurement of equity interest upon acquisition and changes in the fair value of financial instruments (including amounts in discontinued operations) (“Adjusted Pro Forma EBITDA”) (dollars in thousands):
 
Net income attributable to common stockholders   $ 124,728
Pro forma adjustments for current period investments, capital transactions and dispositions 1,456  
Pro forma net income for the three months ended December 31, 2015 126,184
Add back:
Pro forma interest 103,269
Pro forma depreciation and amortization 239,204
Stock-based compensation 3,476
Gain on real estate dispositions (4,162 )
Gain on extinguishment of debt, net (486 )
Loss from unconsolidated entities 223
Noncontrolling interest 332
Loss on re-measurement of equity interest upon acquisition, net 176
Income tax benefit (11,548 )
Change in fair value of financial instruments 454
Other taxes 494
Merger-related expenses, deal costs and re-audit costs (414 )
Adjusted Pro Forma EBITDA 457,202  
Adjusted Pro Forma EBITDA annualized $ 1,828,808  
 
As of December 31, 2015:
Debt $ 11,206,996
Cash, adjusted for cash escrows pertaining to debt (74,246 )
Net debt $ 11,132,750  
 
Net debt to Adjusted Pro Forma EBITDA 6.1   x

 
NON-GAAP FINANCIAL MEASURES RECONCILIATION 1, 2
NOI by Segment
(In thousands)
         
2015 Quarters

2014
Fourth

Fourth Third Second First Quarter
Revenues
 
Triple-Net
Triple-Net Rental Income $ 208,210 $ 201,028 $ 182,006 $ 188,557 $ 174,500
 
Medical Office Buildings
Medical Office - Stabilized 135,642 130,573 129,145 123,210 104,170
Medical Office - Lease up 7,176 8,611 8,129 8,429 6,675
Medical Office - Other 3,140   3,571   3,198   5,421   6,123
Total Medical Office Buildings - Rental Income 145,958   142,755   140,472   137,060   116,968
Total Rental Income 354,168 343,783 322,478 325,617 291,468
 
Medical Office Building Services Revenue 9,370   8,459   7,749   8,858   9,218
Total Medical Office Buildings - Revenue 155,328 151,214 148,221 145,918 126,186
 
Triple-Net Services Revenue 1,147 1,011 1,139 1,136 1,136
Non-Segment Services Revenue 1,024   530   520   549   770
Total Medical Office Building and Other Services Revenue 11,541 10,000 9,408 10,543 11,124
 
Seniors Housing Operating
Seniors Housing - Stabilized 438,649 437,816 438,110 431,890 398,855
Seniors Housing - Lease up 16,222 17,009 16,535 15,024 12,083
Seniors Housing - Other         232
Total Resident Fees and Services 454,871 454,825 454,645 446,914 411,170
 
Non-Segment Income from Loans and Investments 20,361   18,924   25,215   22,053   14,876
Total Revenues, excluding Interest and Other Income 840,941 827,532 811,746 805,127 728,638
 
Property-Level Operating Expenses
 
Medical Office Buildings
Medical Office - Stabilized 43,095 38,593 38,490 36,808 33,332
Medical Office - Lease up 3,235 3,013 3,087 3,242 2,509
Medical Office - Other (1,257 ) 1,699   1,833   2,387   2,970
Total Medical Office Buildings 45,073 43,305 43,410 42,437 38,811
 
Seniors Housing Operating
Seniors Housing - Stabilized 294,288 290,619 286,321 286,277 262,915
Seniors Housing - Lease up 12,973 13,921 12,931 12,085 10,421
Seniors Housing - Other         227
Total Seniors Housing 307,261   304,540   299,252   298,362   273,563
Total Property-Level Operating Expenses 352,334 347,845 342,662 340,799 312,374
 
Medical Office Building Services Costs 7,467 6,416 5,764 6,918 7,527
 
Net Operating Income
 
Triple-Net
Triple-Net Properties 208,210 201,028 182,006 188,557 174,500
Triple-Net Services Revenue 1,147   1,011   1,139   1,136   1,136
Total Triple-Net 209,357 202,039 183,145 189,693 175,636
 
Medical Office Buildings
Medical Office - Stabilized 92,547 91,980 90,655 86,402 70,838
Medical Office - Lease up 3,941 5,598 5,042 5,187 4,166
Medical Office - Other 4,397 1,872 1,365 3,034 3,153
Medical Office Building Services 1,903   2,043   1,985   1,940   1,691
Total Medical Office Buildings 102,788 101,493 99,047 96,563 79,848
 
Seniors Housing Operating
Seniors Housing - Stabilized 144,361 147,197 151,789 145,613 135,940
Seniors Housing - Lease up 3,249 3,088 3,604 2,939 1,662
Seniors Housing - Other         5
Total Seniors Housing 147,610 150,285 155,393 148,552 137,607
Non-Segment 21,385   19,454   25,735   22,602   15,646
Net Operating Income $ 481,140   $ 473,271   $ 463,320   $ 457,410   $ 408,737
 
1 Amounts above are adjusted to exclude discontinued operations for all periods presented.
2 Amounts above are not restated for changes between categories from quarter to quarter.

 
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(Dollars in thousands)
   
Total Portfolio Same-Store Constant Currency Cash NOI
 
For the Three Months Ended For the Year Ended
December 31, December 31,
2015   2014 2015 2014
 
Net Operating Income $ 481,140 $ 408,737 $ 1,875,141 $ 1,560,070
 
Adjustments:
Lease Modification Fee 5,200
NOI Not Included in Same-Store (79,080 ) (18,552 ) (343,815 ) (112,301 )
Straight-Lining of Rental Income (8,674 ) (9,008 ) (33,721 ) (38,553 )
Non-Cash Rental Income (4,163 ) (947 ) (15,456 ) (4,674 )
Non-Segment NOI (21,385 ) (15,644 ) (89,176 ) (54,048 )
Constant Currency Adjustment   (2,874 )   (3,193 )
(113,302 ) (47,025 ) (476,968 ) (212,769 )
 
Constant Currency NOI as Reported $ 367,838   $ 361,712   $ 1,398,173   $ 1,347,301  
 
Percentage Increase 1.7 % 3.8 %
 
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(Dollars in thousands)
 
Triple-Net Portfolio Same-Store Constant Currency Cash NOI
 
For the Year Ended
December 31,
2015   2014
 
Net Operating Income $ 784,234 $ 679,112
 
Adjustments:
Lease Modification Fee 5,200
NOI Not Included in Same-Store (129,030 ) (55,291 )
Straight-Lining of Rental Income (18,964 ) (26,473 )
Non-Cash Rental Income (18,681 ) (8,840 )
(161,475 ) (90,604 )
 
Constant Currency NOI as Reported $ 622,759   $ 588,508  
 
Percentage Increase 5.8 %

 
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(Dollars in thousands)
 
Senior Housing Operating Portfolio Same-Store Constant Currency Cash NOI
 
For the Year Ended
December 31,
2015   2014
 
Net Operating Income $ 601,840 $ 516,395
 
Less:
NOI Not Included in Same-Store (109,706 ) (32,203 )
Constant Currency Adjustment   (3,193 )
(109,706 ) (35,396 )
 
Constant Currency NOI as Reported $ 492,134   $ 480,999  
 
Percentage Increase 2.3 %
 
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(Dollars in thousands)
 
MOB Portfolio Same-Store Constant Currency Cash NOI
 
For the Year Ended
December 31,
2015   2014
 
Net Operating Income $ 399,891 $ 310,515
 
Adjustments:
NOI Not Included in Same-Store (105,079 ) (24,807 )
Straight-Lining of Rental Income (14,758 ) (12,080 )
Non-Cash Rental Income 3,225   4,166  
(116,612 ) (32,721 )
 
Constant Currency NOI as Reported $ 283,279   $ 277,794  
 
Percentage Increase 2.0 %
 

Click here to subscribe to Mobile Alerts for Ventas, Inc.